Results 191 to 200 of about 12,492 (212)

Immuno-imaging using nanobodies

Current Opinion in Biotechnology, 2011
Immuno-imaging is a developing technology that aims at studying disease in patients using imaging techniques such as positron emission tomography in combination with radiolabeled immunoglobulin derived targeting probes. Nanobodies are the smallest antigen-binding antibody-fragments and show fast and specific targeting in vivo.
Vaneycken, Ilse, D'Huyvetter, Matthias, Hernot, Sophie, De Vos, Jens, Xavier, Catarina, Devoogdt, Nick, Caveliers, Vicky, Lahoutte, Tony   +7 more
openaire   +3 more sources

Nanobody-Based Chromatin Immunoprecipitation

2012
Chromatin immunoprecipitation (ChIP), followed by microarray hybridization (ChIP-chip) or high-throughput sequencing (ChIP-seq), is becoming a widely used powerful method for the analysis of the in vivo DNA-protein interactions at genomic scale.The success of ChIP largely depends on the quality of antibodies.
NGUYEN DUC, Trong, Hassanzadeh Ghassabeh, Gholamreza, Saerens, Dirk, Peeters, Eveline, Charlier, Daniel, Muyldermans, Serge   +5 more
openaire   +3 more sources

Exploiting Nanobodies’ Singular Traits

Annual Review of Immunology, 2018
The unique class of heavy chain–only antibodies, present in Camelidae, can be shrunk to just the variable region of the heavy chain to yield VHHs, also called nanobodies. About one-tenth the size of their full-size counterparts, nanobodies can serve in applications similar to those for conventional antibodies, but they come with a number of signature ...
Jessica R, Ingram, Florian I, Schmidt, Hidde L, Ploegh   +2 more
openaire   +2 more sources

Nanobodies and Their Potential Applications

Nanomedicine, 2013
Nanobodies are recombinant, antigen-specific, single-domain, variable fragments of camelid heavy chain-only antibodies. The innate supremacy of nanobodies as a renewable source of affinity reagents, together with their high production yield in a broad variety of expression systems, minimal size, great stability, reversible refolding and outstanding ...
Gholamreza Hassanzadeh-Ghassabeh, Nick Devoogdt, Pieter De Pauw, Cécile Vincke, Serge Muyldermans   +4 more
openaire   +3 more sources

Nanobody pharmacology

Science Signaling
Antibody fragments can act as pharmacological tools to modulate the functions of G protein–coupled receptors.
openaire   +2 more sources

Trends in nanobody radiotheranostics

European Journal of Nuclear Medicine and Molecular Imaging
As the smallest antibody fragment with specific binding affinity, nanobody-based nuclear medicine has demonstrated significant potential to revolutionize the field of precision medicine, supported by burgeoning preclinical investigations and accumulating clinical evidence.
Xingru Long, Sixuan Cheng, Xiaoli Lan, Weijun Wei, Dawei Jiang   +4 more
openaire   +2 more sources

Optogenetic Activation of Intracellular Nanobodies

2022
Intracellular antibody fragments such as nanobodies and scFvs are powerful tools for imaging and for modulating and neutralizing endogenous target proteins. Optogenetically activated intracellular antibodies (optobodies) constitute a light-inducible system to directly control intrabody activities in cells, with greater spatial and temporal resolution ...
Daseuli, Yu, Heo, Won Do
openaire   +2 more sources

Nanobodies in therapeutic applications.

Current opinion in molecular therapeutics, 2007
Over the years, many antibodies have been successfully generated to treat patients with life-threatening diseases, most notably cancer. While the first generation of antibodies, originating from mice, caused severe side effects and were relatively inefficient, technological advances have made it possible to obtain fully human antibodies for therapeutic
Roovers, Rob C., Van Dongen, G. A M S, Van Bergen En Henegouwen, P. M P   +2 more
openaire   +3 more sources

Nanobodies: Natural Single-Domain Antibodies

Annual Review of Biochemistry, 2013
Sera of camelids contain both conventional heterotetrameric antibodies and unique functional heavy (H)-chain antibodies (HCAbs). The H chain of these homodimeric antibodies consists of one antigen-binding domain, the VHH, and two constant domains.
openaire   +3 more sources

Nanobody exchange chromatography

2021
The present invention relates to the field of affinity purification and provides for means and methods applying protein binding agents competing for a target protein for use as capture and elution tool, wherein the elution agent comprises an immunoglobulin single variable domain (ISVD), and is capable of displacing the capturing binding agent.
Steyaert, Jan, Pardon, Els, Wohlkönig, Alexandre, Zögg, Thomas, Kalichuk, Valentina, De Keyser, Phebe, Fischer, Baptiste   +6 more
openaire   +2 more sources